Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (698) Arrow Down
Filter Results: (698) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (698)
    • People  (1)
    • News  (80)
    • Research  (510)
    • Events  (3)
  • Faculty Publications  (226)

Show Results For

  • All HBS Web  (698)
    • People  (1)
    • News  (80)
    • Research  (510)
    • Events  (3)
  • Faculty Publications  (226)
← Page 11 of 698 Results →
  • Research Summary

Selling China: Foreign Direct Investment During the Reform Era

The aim of the book is to illustrate the dynamics of foreign direct investment (FDI) in China in the 1990s. The topic is important both because China is the world's second largest recipient of FDI and because there are substantial misconceptions about the drivers of... View Details
  • 06 Aug 2020
  • Blog Post

WHY WE STARTED THE HBS BLACK INVESTMENT CLUB

INSPIRED BY RECENT EVENTS The protests against the unjust murders of George Floyd, Ahmaud Arbery, Breonna Taylor, and countless others since have mobilized the nation to take a stand in support of the Black Lives Matter (BLM) movement and against the many View Details
Keywords: All Industries
  • 10 Oct 2007
  • First Look

First Look: First Look: October 10

  Working PapersTesting Limits to Policy Reversal: Evidence from Indian Privatizations Authors:Siddhartha G. Dastidar, Raymond Fisman, and Tarun Khanna Abstract We examine the effect of regime change on privatization using the 2004... View Details
Keywords: Martha Lagace
  • October 26, 2015
  • Article

Measuring and Communicating Health Care Value with Charts

By: Robert S. Kaplan, Robin P. Blackstone, Derek A. Haas and Nikhil G. Thaker
The goal of a health care system should be to deliver the most value to patients: the outcomes achieved for treating a medical condition relative to the costs incurred over a complete care cycle. We have found that a radar (spider web) chart is an effective means to... View Details
Keywords: Service Delivery; Value; Health Care and Treatment; Health Industry
Citation
Register to Read
Related
Kaplan, Robert S., Robin P. Blackstone, Derek A. Haas, and Nikhil G. Thaker. "Measuring and Communicating Health Care Value with Charts." Harvard Business Review (website) (October 26, 2015). (A collaboration of the editors of Harvard Business Review and the New England Journal of Medicine.)
  • 18 Apr 2024
  • Lecture

Innovation Opportunities Created by COVID-19 Can Help: And How to Make Them Happen

By: Regina E. Herzlinger
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
Keywords: Policy; Health Pandemics; Health Care and Treatment; Innovation and Invention; Health Industry; Insurance Industry
Citation
Related
"Innovation Opportunities Created by COVID-19 Can Help: And How to Make Them Happen." Fortnightly of Chicago, April 18, 2024.
  • Web

Marketing - Faculty & Research

than has been portrayed thus far in the extant literature by taking an ecosystem perspective. This broader outlook allows examining not only the product strategies of the firms in the focal industry and their mapping to specific customer segments, as in classic View Details
  • 3 Jun 2023
  • Talk

Health Care Innovation Opportunities Created by COVID-19 and How to Make Them Happen

By: Regina E. Herzlinger
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
Keywords: Policy; Health Pandemics; Health Care and Treatment; Innovation and Invention; Health Industry; Insurance Industry
Citation
Related
Herzlinger, Regina E. "Health Care Innovation Opportunities Created by COVID-19 and How to Make Them Happen." Harvard Business School Alumni Reunion, Boston, MA, June 3, 2023. (Link to cases described in this talk.)
  • June 2004
  • Case

Medical Technology Industry and Japan (A), The

In a five-year effort, the Health Industry Manufacturers Association (HIMA) tried to influence government health policy in Japan. In 1993, HIMA mobilized in response to fears the Japanese government was planning to target the U.S. medical devices industry. The case... View Details
Keywords: Health Care and Treatment; Policy; Globalized Markets and Industries; Government and Politics; Medical Devices and Supplies Industry; Japan; United States
Citation
Educators
Purchase
Related
Watkins, Michael D., and Terri Zavada. "Medical Technology Industry and Japan (A), The." Harvard Business School Case 904-018, June 2004.
  • September 2013
  • Article

Testimonials Do Not Convert Patients from Brand to Generic Medication

By: John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn Reynolds

Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to lower-cost therapeutic equivalents, and whether the testimonial's efficacy increases when... View Details

Keywords: Testimonial; Peer Information; Social Proximity; Communication; Generic Medication; Familiarity; Marketing Communications; Decision Choices and Conditions; Identity; Health Care and Treatment; Marketing Reference Programs; Power and Influence; Brands and Branding; Health Industry
Citation
Read Now
Related
Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds. "Testimonials Do Not Convert Patients from Brand to Generic Medication." American Journal of Managed Care 19, no. 9 (September 2013): e314–e316.
  • August, 2022
  • Article

Billing and Insurance-Related Administrative Costs: A Cross-National Analysis

By: Barak D. Richman, Robert S. Kaplan, Japees Kohli, Dennis Purcell, Mahek Shah, Igna Bonfrer, Brian Golden, Rosemary Hannam, Will Mitchell, Daniel Cehic, Garry Crispin and Kevin A. Schulman
Billing and insurance-related costs are a significant source of wasteful health care spending in Organization for Economic Cooperation and Development nations, but these administrative burdens vary across national systems. We executed a microlevel accounting of these... View Details
Keywords: Health Care Costs; Administrative Costs; Cost; Health Care and Treatment; Health Industry
Citation
Find at Harvard
Register to Read
Related
Richman, Barak D., Robert S. Kaplan, Japees Kohli, Dennis Purcell, Mahek Shah, Igna Bonfrer, Brian Golden, Rosemary Hannam, Will Mitchell, Daniel Cehic, Garry Crispin, and Kevin A. Schulman. "Billing and Insurance-Related Administrative Costs: A Cross-National Analysis." Health Affairs 41, no. 8 (August, 2022): 1098–1106.
  • Web

Program Requirements - Doctoral

by completing a teaching fellow or instructor assignment at a Harvard University. Qualifying Exams Health Policy General Exam: This exam tests candidate’s general knowledge of health View Details
  • 2007
  • Book

Perspectives on Risk and Regulation: The FDA at 100

By: Arthur A. Daemmrich and Joanna Radin
Perspectives on Risk and Regulation: The FDA at 100 brings together the viewpoints of Food and Drug Administration officials and industry leaders on the future of regulating food, drugs, medical devices, and dietary supplements. In a period of rapid scientific... View Details
Keywords: Private Sector; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Business and Government Relations; Risk and Uncertainty; Cooperation
Citation
Find at Harvard
Read Now
Related
Daemmrich, Arthur A., and Joanna Radin, eds. Perspectives on Risk and Regulation: The FDA at 100. Chemical Heritage Foundation, 2007. (Fulltext.)
  • 28 Nov 2011
  • Research & Ideas

Rethinking the Fairness of Organ Transplants

Vivek F. Farias, both of MIT's Sloan School—can help policy designers create the most equitable point system based on their chosen constraints and criteria. They detail the proposed model in a new paper, Fairness, Efficiency and... View Details
Keywords: by Dennis Fisher; Health
  • 13 Jan 2015
  • First Look

First Look: January 13

voluntary disclosure and marketing decisions. Publisher's link: http://people.hbs.edu/mluca/StrategicDisclosure.pdf January 2015 Innovation Policy and the Economy Firms and the Economics of Skilled Immigration By: Pekkala Kerr, Sari,... View Details
Keywords: Sean Silverthorne
  • Web

Technology & Operations Management - Faculty & Research

alternatives. Many users dismiss banners without making an explicit choice, underscoring the importance of default settings. Survey evidence further reveals substantial confusion about default settings. Using a structural model, we find that among consent View Details
  • 26 Mar 2013
  • First Look

First Look: March 26

treatment has very large effects on whether respondents view inequality as an important problem. By contrast, we find quantitatively small effects of the treatment on views about View Details
Keywords: Sean Silverthorne
  • November 2024
  • Article

The Health Costs of Cost Sharing

By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
What happens when patients suddenly stop their medications? We study the health consequences of drug interruptions caused by large, abrupt, and arbitrary changes in price. Medicare’s prescription drug benefit as-if-randomly assigns 65-year-olds a drug budget as a... View Details
Keywords: Outcome or Result; Health Care and Treatment; Budgets and Budgeting; Cost
Citation
Read Now
Related
Chandra, Amitabh, Evan Flack, and Ziad Obermeyer. "The Health Costs of Cost Sharing." Quarterly Journal of Economics 139, no. 4 (November 2024): 2037–2082.
  • August 2017
  • Case

Infection Control at Massachusetts General Hospital (Abridged)

By: Robert S. Huckman and Nikolaos Trichakis
The case explores the challenges facing Massachusetts General Hospital concerning the adoption of a new infection control policy, which promises to improve operational performance, patient safety, and profitability. The new policy requires coordination between... View Details
Keywords: Safety; Organizational Change and Adaptation; Integration; Health Care and Treatment; Policy; Health Industry; Boston
Citation
Educators
Purchase
Related
Huckman, Robert S., and Nikolaos Trichakis. "Infection Control at Massachusetts General Hospital (Abridged)." Harvard Business School Case 618-018, August 2017.
  • Web

South Asia - Global

South Asia Mumbai For the past decade the HBS community has demonstrated a strong interest in research related to South Asia. The India Research Center (IRC) was established in 2006 and is based in Mumbai. Following significant economic View Details
  • Web

Finance - Faculty & Research

Aparna Krishna This paper evaluates a low-cost, customized soil nutrient management advisory service in India. As a methodological contribution, we examine whether and in which settings satellite measurements may be effective at estimating both agricultural yields and... View Details
  • ←
  • 11
  • 12
  • …
  • 34
  • 35
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.